← Leaderboards
David Alan Hunstad
Washington University
$9,034,462
Attributed
$10,777,309
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,777,309 · 13
By mechanism
R01$8,939,118 · 5
T32$1,023,191 · 1
K08$628,890 · 1
R03$150,584 · 1
P41$35,526 · 5
Top collaborators
- Ashlee Miriam Earl5 shared
- Anthony R French4 shared
- Megan Anne Cooper2 shared
Most similar at Washington University
Same institution · by research overlap
- Scott J Hultgren$48,876,558
- Sarki A. Abdulkadir$18,466,452
- Nupam P Mahajan$8,775,560
- Ellen F Binder$6,864,946
- Kenneth B. Schechtman$8,169,265
Others in their field
Top investigators on “Urinary Tract Infection”
- Scott J Hultgren · Washington University$42,943,440
- Margaret Rita Karagas · Dartmouth College$30,772,632
- Harry L. Mobley · University Of Maryland Baltimore$20,366,606
- Evgeni Veniaminovic Sokurenko · University Of Washington$15,787,865
- Theoklis Zaoutis · Children'S Hosp Of Philadelphia$15,187,649
- Ashlee Miriam Earl · University Of California-Irvine$12,588,978
Research focus
Urinary Tract InfectionBladderUropathogenic E. ColiUrinary TractEpithelial CellsCommunitiesPathogenesisRecurrenceInfectionCystitisBacteriaIn VitroCommunicable DiseasesPathogenCellsProteinsPilumMorbidity - Disease RatePhenotypeVirulenceResponseKidney InfectionAntibioticsEscherichia Coli
Grant awards (42)
Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI$393,750
R01 · FY2025 · AI · contact PI
Pediatric Infectious Diseases and Immunity Training Program$192,085
T32 · FY2025 · AI · contact PI
Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis$487,490
R01 · FY2024 · DK · contact PI
Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI$393,750
R01 · FY2024 · AI · contact PI
Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis$507,802
R01 · FY2023 · DK · contact PI
Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI$393,750
R01 · FY2023 · AI · contact PI
Pediatric Infectious Diseases and Immunity Training Program$161,742
T32 · FY2023 · AI · contact PI
Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis$507,805
R01 · FY2022 · DK · contact PI
Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI$393,750
R01 · FY2022 · AI · contact PI
Pediatric Infectious Diseases and Immunity Training Program$152,944
T32 · FY2022 · AI · contact PI
Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis$472,516
R01 · FY2021 · DK · contact PI
Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI$393,750
R01 · FY2021 · AI · contact PI
ANDROGEN INFLUENCE ON UTI SUSCEPTIBILITY AND SEVERITY$354,375
R01 · FY2021 · DK · contact PI
Pediatric Infectious Diseases and Immunity Training Program$160,966
T32 · FY2021 · AI · contact PI
Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis$486,891
R01 · FY2020 · DK · contact PI
ANDROGEN INFLUENCE ON UTI SUSCEPTIBILITY AND SEVERITY$354,188
R01 · FY2020 · DK · contact PI
Pediatric Infectious Diseases and Immunity Training Program$181,194
T32 · FY2020 · AI · contact PI
ANDROGEN INFLUENCE ON UTI SUSCEPTIBILITY AND SEVERITY$352,688
R01 · FY2019 · DK · contact PI
Pediatric Infectious Diseases and Immunity Training Program$174,260
T32 · FY2019 · AI · contact PI
ANDROGEN INFLUENCE ON UTI SUSCEPTIBILITY AND SEVERITY$349,875
R01 · FY2018 · DK · contact PI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION$305,037
R01 · FY2014 · DK · contact PI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION$294,512
R01 · FY2013 · DK · contact PI
THE OUTER MEMBRANE AS A VIRULENCE PLATFORM$287,522
R01 · FY2013 · DK · contact PI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION$305,348
R01 · FY2012 · DK · contact PI
THE OUTER MEMBRANE AS A VIRULENCE PLATFORM$297,950
R01 · FY2012 · DK · contact PI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION$305,496
R01 · FY2011 · DK · contact PI
THE OUTER MEMBRANE AS A VIRULENCE PLATFORM$297,950
R01 · FY2011 · DK · contact PI
TARGETING THE E COLI CHAPERONE SURA IN RECURRENT UTI$6,075
P41 · FY2011 · RR · contact PI
ADHESIN-BASED NANOTHERAPEUTICS IN URINARY TRACT INFECTION$397,963
R01 · FY2010 · DK · contact PI
THE OUTER MEMBRANE AS A VIRULENCE PLATFORM$300,960
R01 · FY2010 · DK · contact PI
TARGETING THE E COLI CHAPERONE SURA IN RECURRENT UTI$9,710
P41 · FY2010 · RR · contact PI
THE OUTER MEMBRANE AS A VIRULENCE PLATFORM$304,000
R01 · FY2009 · DK · contact PI
TARGETING THE E COLI CHAPERONE SURA IN RECURRENT UTI$5,825
P41 · FY2009 · RR · contact PI
Host Responses to E. Coli Urinary Tract Infection$125,578
K08 · FY2008 · DK · contact PI
Targeting the E. coli chaperone SurA in recurrent UTI$74,480
R03 · FY2008 · DK · contact PI
TARGETING THE E COLI CHAPERONE SURA IN RECURRENT UTI$6,958
P41 · FY2008 · RR · contact PI
HOST RESPONSES TO E COLI URINARY TRACT INFECTION$6,958
P41 · FY2008 · RR · contact PI
Host Responses to E. Coli Urinary Tract Infection$125,578
K08 · FY2007 · DK · contact PI
Targeting the E. coli chaperone SurA in recurrent UTI$76,104
R03 · FY2007 · DK · contact PI
Host Responses to E. Coli Urinary Tract Infection$126,578
K08 · FY2006 · DK · contact PI
Host Responses to E. Coli Urinary Tract Infection$125,578
K08 · FY2005 · DK
Host Responses to E. Coli Urinary Tract Infection$125,578
K08 · FY2004 · DK